It’s not often in the world of investing that you find stocks with the realistic potential to double, triple or even more, but Adamis Pharmaceuticals Corp (NASDAQ:ADMP) is one with that type of potential and they have more than one weapon. Adamis Pharmaceuticals Corp (NASDAQ:ADMP), shares after opening at $5.69 moved to $5.89 on last trade day and at the end of the day closed at $5.83. Company price to cash ratio as 12.99. Adamis Pharmaceuticals Corp (NASDAQ:ADMP), showed a negative weekly performance of 3.80%.
MacroGenics Inc (NASDAQ:MGNX) saw a big move last session, as the company’s shares fell by nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for MGNX as the stock is now down over 39% since March 20. MacroGenics Inc (NASDAQ:MGNX), shares advanced 4.00% in last trading session and ended the day on $24.17. MacroGenics Inc (NASDAQ:MGNX), return on equity ratio is recorded as 32.00% and its return on assets is -8.40%.
For the purposes of familiarity, RadNet Inc. (NASDAQ:RDNT) is a diagnostic imaging company. This $154 million company owns about 250 imaging facilities which are spread in seven states. RadNet Inc. (NASDAQ:RDNT), shares moved up 0.97% in last trading session and was closed at $4.17, while trading in range of $ 3.85 – 4.27. RadNet Inc. (NASDAQ:RDNT), year to date (YTD) performance is 149.70%.
Mallinckrodt PLC (NYSE:MNK), with its registered headquarters in Dublin and run from Hazelwood, Missouri, will pay cash and stock valued at $86.08 a share for Questcor, the companies said in a statement. That’s 27 percent above the April 4 closing price for Anaheim, California-based Questcor. Mallinckrodt PLC (NYSE:MNK), weekly performance is 8.02%. On last trading day company shares ended up $67.78. Mallinckrodt PLC (NYSE:MNK), distance from 50-day simple moving average (SMA50) is 3.96%. Analysts mean target Price for the company is $65.00.